Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Melasma
Interventions
DRUG

290-400 nm sunscreen

A broad UV spectrum sunscreen will be applied every 3 hours for 12 weeks. The affected surface will be covered with a 2 mg/cm\^2 layer of the product as indicated on the affected areas of the face.

DRUG

290-800 nm sunscreen

A UV-visible light spectrum sunscreen will be applied every 3 hours for 12 weeks. The affected surface will be covered with a 2 mg/cm\^2 layer of the product as indicated on the affected areas of the face.

Trial Locations (1)

78210

"Dermatology Department. Hospital Central Dr. Ignacio Morones Prieto", San Luis Potosí City

All Listed Sponsors
collaborator

"Hospital Central Dr. Ignacio Morones Prieto"

OTHER

lead

Universidad Autonoma de San Luis Potosí

OTHER

NCT01695356 - Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma | Biotech Hunter | Biotech Hunter